Prognostic role of metformin in diabetes mellitus type 2 patients with hepatocellular carcinoma: A systematic review and meta-analysis.

World J Diabetes · 2023 · PMC10473950 · PMID 37664473

Europe PMC DOI

hedged sentence

0.4200

closest p · 8.4× alpha

0.4200

boldest claim

The sentences

did not reach statistical significanceP = 0.42not close (p > 0.1)

The summary OR (95%CI) showed a decreased risk of death in T2DM cases receiving metformin, although this value did not reach statistical significance (OR = 0.89, 95%CI: 0.67-1.18; P = 0.42) (Figure 3A ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.